Commitments and Contingencies (Details) $ in Millions |
1 Months Ended | 3 Months Ended | |||
---|---|---|---|---|---|
Dec. 07, 2022
USD ($)
|
Jan. 16, 2019
class_action
|
Jun. 30, 2022
USD ($)
|
Mar. 31, 2023
USD ($)
|
Sep. 15, 2022
USD ($)
|
|
Loss Contingencies [Line Items] | |||||
Payments for legal settlements | $ 0.2 | ||||
Number of securities class actions | class_action | 2 | ||||
Turn Therapeutics | |||||
Loss Contingencies [Line Items] | |||||
Long-term purchase commitment amount | $ 9.6 | ||||
Research and Development Arrangement | Nordic Bioscience Clinical Development A/S | |||||
Loss Contingencies [Line Items] | |||||
Long-term purchase commitment amount | $ 10.2 | ||||
Payments made on long-term purchase commitment | 3.6 | ||||
Expenses on long-term purchase commitment | 0.6 | ||||
Remaining prepaid expenses on long-term purchase commitment | 2.2 | ||||
Chief Executive Officer | Separation Agreement | |||||
Loss Contingencies [Line Items] | |||||
Other commitment | 3.1 | $ 3.1 | |||
Other commitments paid | 0.9 | ||||
Other Commitment, Current | 1.6 | ||||
Other Commitment, Noncurrent | $ 0.6 |